De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT06934564
- Status
- Recruiting
Conditions
- Breast Lumpectomy
- Inguinal Hernia Repair
- Laparoscopic Cholecystectomy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Active de-Implementation — BEHAVIORALDuring active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.
Study Details
This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.
Key Dates
- Start date
- Apr 1, 2025
- Status verified
- May 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 16 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Wave 1Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 2
- Experimental: Wave 2Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 3
- Experimental: Wave 3Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 4
- Experimental: Wave 4Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 1
- Experimental: Wave 5Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 2
- Experimental: Wave 6Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 3
Primary Outcome Measure
Number of tests within 30 days of surgery not associated with an emergency department visit [ Time Frame: Within 30 days of surgery ]
Central Contacts
- Dana Greene Jr., MPH(313)-670-0408
- Valerie Gavrila734-232-9961
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan and other Michigan Surgical Quality Collaborative sites | Ann Arbor | Michigan | 48109 | Lesly Dossett, MD, MPH (PRINCIPAL_INVESTIGATOR) Hari Nathan, PhD (SUB_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
Related Studies
- Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic SystemRecruiting · Distalmotion SA · Buffalo, New York